Correction: Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2 Breast Cancer.

Hanker AB, Estrada MV, Bianchini G, Moore PD, Zhao J, Cheng F, Koch JP, Gianni L, Tyson DR, Sánchez V, Rexer BN, Sanders ME, Zhao Z, Stricker TP, Arteaga CL
Cancer Res. 2019 79 (4): 873

PMID: 30770368 · DOI:10.1158/0008-5472.CAN-18-4085

MeSH Terms (0)

Connections (1)

This publication is referenced by other Labnodes entities:

Links